| ETEPLIRSEN | None | ||
| 100MG/2ML, 500MG/10ML |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| EXONDYS 51 is an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. | |||
|
Yes
| |||
| EXONDYS 51 | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||
| ***** *** ******* *** ************* ****** ********* | ************ *** ******** ******** ********* | ************ *** ******** ******** ********* | ************ *** ******** ******** ********* | ********* **************** *** ******** **** ******** *** ******* ** *** ******* | ***** *** ******* *** ************* ****** ********* | ******-****** ********* *********** *** ****** | ******-****** ********* *********** *** ****** | ********* **************** *** ******** **** ******** *** ******* ** *** ******* | ********* **************** *** ******** **** ******** *** ******* ** *** ******* | ********* **************** *** ******** **** ******** *** ******* ** *** ******* | ********* **************** *** ******** **** ******** *** ******* ** *** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|